BD Buys Privately-held GenCell Biosystems; Financial Details Not Disclosed

(RTTNews) - Medical technology company Becton, Dickinson and Co. (BDX), or BD, on Monday said it has bought GenCell Biosystems, a privately-held Irish biotech company, for undisclosed financial terms.

GenCell has developed an automated platform which can address key unmet customer needs in library preparation for Next Generation Sequencing. With this acquisition, BD will have access to the Next Generation Sequencing market, that will provide a base to further grow the company's genomics offerings.

The company said the expected impact of this acquisition will be reflected in its guidance, which will be reported during the group's fourth quarter earnings call.